The CGAS STING Pathway Market involves products and therapies targeting the cyclic GMP-AMP synthase (cGAS) – stimulator of interferon genes (STING) pathway. This pathway serves as a critical innate immune sensor that detects cytosolic DNA and triggers type I interferon responses. Key products in this market include STING agonists and antagonists that aim to boost or suppress immune...